Squamous Cell Carcinoma of the Skin
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00530 | Erlotinib | 1 / 2 | Withdrawn | 1 |
| DB06075 | Linsitinib | 1 / 2 | Withdrawn | 1 |
| DB11945 | Avelumab | 2 | Recruiting | 1 |
| DB01101 | Capecitabine | 2 | Terminated | 1 |
| DB01254 | Dasatinib | 2 | Completed | 1 |
| DB00317 | Gefitinib | 2 | Completed | 1 |
| DB01132 | Pioglitazone | 2 | Enrolling by Invitation | 1 |
| DB00002 | Cetuximab | Not Available | Recruiting | 1 |
| DB01042 | Melphalan | Not Available | Withdrawn | 1 |